← All trials
NCT04610866
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Dec 9, 2020
- Primary completion
- Oct 19, 2021
- Completion date
- Oct 19, 2023
- First posted
- Nov 2, 2020
- Last posted
- Dec 11, 2020
- Enrollment
- 15
- Arms / groups
- 1 / —
- Source
- AACT · ingestion pipeline
Sponsors
- National Heart, Lung, and Blood Institute (NHLBI)Lead sponsor
- National Heart, Lung, and Blood Institute (NHLBI)Overall official - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.